• Havea-group-500x367.png
    Havea Group
    France / Private Equity



    Havea Group is a leader in the Natural Consumer Healthcare industry in Europe. It manufactures, designs and distributes a wide range of products from functional and natural food supplements, to natural personal care products for babies and women through its world class plant in France. Havea is well positioned due to its multi-distribution channel strategy and owns several well-known brands including Vitarmonyl, Biolane, Manhaé, Ultrabiotique, Naturémoi and acquired Aragan / Synactifs and Suvéal Duo brands respectively in 2017 and 2018 to strengthen Havea's presence in the pharmacy channel.

    Since inception, Havea has grown year double digit each year organically and is well positioned to benefit from the consolidation taking place in this highly fragmented market and will continue to expand its international footprint in Europe, Asia and the Americas.


    • Strong future organic growth expected stemming from global mega trends in natural healthcare and well-being
    • Introduced Philippe Charrier, a seasoned leader in the FMCG and Natural Consumer Healthcare, as President and CEO via our Business Leaders Network
    • Supporting the management team to implementing a complete digital strategy
    • Supporting M&A opportunities using our global network and strong experience which led to the acquisitions of Aragan within a few months of our ownership and Densmore in July 2018
    "3i is a great partner for Havea; its values and approach really fits well with our entrepreneurial approach. They relentlessly look for growth while keeping the right balance with operational performance improvement, and robustness and digitalization of the core processes. In 2 years with 3i we have doubled the size of the Group, made 3 acquisitions including my own company” Nicolas Brodetzky, CEO, Havea

    Regulatory information 
    This transaction involved a recommendation of 3i Investments plc, advised by 3i France.

Back to top